Skip to content

Clinical trials

Phase 4 Autism Spectrum Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 4 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20102
20111
20141
20171
20181
20192
20222
20231
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital5
Cambridge Health Alliance1
Children's Hospital Medical Center, Cincinnati1
Daniel Coury1
David Cochran1
Drexel University1
Gagan Joshi1
Montefiore Medical Center1
University of Chicago1
University of Nebraska1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder16
Autistic Disorder8
Attention Deficit Disorder with Hyperactivity3
Anxiety Disorders2
Asperger Syndrome2
Obesity2
Weight Gain2
Bipolar Disorder1
Child Development Disorders, Pervasive1
Drug-Related Side Effects and Adverse Reactions1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.